MedPath

EQUIDACENT 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

EQUIDACENT 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Pending
Register Number

1201472001

Prescription Type

Uso Hospitalario

Authorization Date

Dec 28, 2020

Dosage Form

CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1201472001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
Yes
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

BEVACIZUMABActive
Quantity: 100 mg
Name: BEVACIZUMAB

ATC CLASSIFICATION (3)

L01F
L01FG
L01FG01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.